Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Symanowski

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Urologic Oncology|January 21, 2019
Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesionsEarle F Burgess, Chad Livasy, Aaron Hartman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
JCO Oncology Practice|February 12, 2020
Pain Management Using Clinical Pharmacy Assessments With and Without Pharmacogenomics in an Oncology Palliative Medicine ClinicJai N Patel, Danielle Boselli, Issam S Hamadeh, et al.
JCO Oncology Practice|November 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical PracticeNilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, et al.
JCO Clinical Cancer Informatics|July 15, 2022
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved PatientsCarol J Farhangfar, Gregory T Scarola, Victoria A Morris, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Clinical Genitourinary Cancer|May 2, 2024
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With ChemotherapyLandon C Brown, Myra Robinson, Michael McCormack, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Urologic Oncology|January 21, 2019
Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesionsEarle F Burgess, Chad Livasy, Aaron Hartman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
JCO Oncology Practice|February 12, 2020
Pain Management Using Clinical Pharmacy Assessments With and Without Pharmacogenomics in an Oncology Palliative Medicine ClinicJai N Patel, Danielle Boselli, Issam S Hamadeh, et al.
JCO Oncology Practice|November 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical PracticeNilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, et al.
JCO Clinical Cancer Informatics|July 15, 2022
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved PatientsCarol J Farhangfar, Gregory T Scarola, Victoria A Morris, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Clinical Genitourinary Cancer|May 2, 2024
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With ChemotherapyLandon C Brown, Myra Robinson, Michael McCormack, et al.
Pageof 4